CHE-UN Stock Analysis: Chemtrade Logistics Income | TO
Chemicals | TO, Canada | Market Cap: 1.642m CAD | 12M Return: 16.3% | CA16387P1036 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 2.26M
EPS Trend: -50.8%
Qual. Beats: 0
Rev. Trend: 77.0%
Qual. Beats: 1
Warnings
Tailwinds
No distinct edge detected
Seasonality 11.8 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Chemtrade Logistics Income Fund is a Canadian materials company that supplies industrial chemicals and processing services across Canada, the United States, and Brazil. Its business operates through Sulphur and Water Chemicals and Electrochemicals.
Its products include sulphuric acid, water-treatment coagulants, chlor-alkali chemicals, and sodium chlorate. The company also processes spent acid and industrial by-products. Its customers span sectors including water treatment, pulp and paper, mining, agriculture, and semiconductors-industries that use chemicals in production and treatment processes.
- Sulphuric acid prices and volumes drive SWC earnings
- Caustic soda prices and power costs swing EC margins
- Water-treatment demand and regulations support coagulant sales
| Net Income: 148.9m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.08 > 0.02 and ΔFCF/TA 2.40 > 1.0 |
| NWC/Revenue: 1.56% < 20% (prev -19.39%; Δ 20.95% < -1%) |
| CFO/TA 0.15 > 3% & CFO 394.4m > Net Income 148.9m |
| Net Debt (1.44b) to EBITDA (539.8m): 2.67 < 3 |
| Current Ratio: 1.07 > 1.5 & < 3 |
| Outstanding Shares: last quarter (138.4m) vs 12m ago 21.73% < -2% |
| Gross Margin: 20.26% > 18% (prev 24.22%; Δ -3.96% > 0.5%) |
| Asset Turnover: 86.80% > 50% (prev 84.53%; Δ 2.26% > 0%) |
| Interest Coverage Ratio: 2.85 > 6 (EBIT TTM 310.8m / Interest Expense TTM 109.2m) |
| A: 0.01 (Total Current Assets 483.9m - Total Current Liabilities 450.8m) / Total Assets 2.65b |
| B: -0.38 (Retained Earnings -1.00b / Total Assets 2.65b) |
| C: 0.13 (EBIT TTM 310.8m / Avg Total Assets 2.44b) |
| D: 0.44 (Book Value of Equity 805.7m / Total Liabilities 1.84b) |
| Altman-Z'' = 0.16 = B |
| DSRI: 1.07 (Receivables 232.4m/192.7m, Revenue 2.12b/1.88b) |
| GMI: 1.20 (GM 24.22% / 20.26%) |
| AQI: 1.05 (AQ_t 0.32 / AQ_t-1 0.31) |
| SGI: 1.12 (Revenue 2.12b / 1.88b) |
| TATA: -0.09 (NI 148.9m - CFO 394.4m) / TA 2.65b) |
| Beneish M = -2.68 (Cap -4..+1) = A |
As of October 30, 2026, the stock is trading at CAD 14.77 with a total of 149,206 shares traded. Over the past week, the price has changed by +1.16%, over one month by +2.36%, over three months by -9.65% and over the past year by +16.33%.
Current recommended Stop Loss: 14.00 (which is 5.2% or 3.1 ATR below the current price).
Chemtrade Logistics Income has no consensus analysts rating.
P/E Trailing = 11.4375
P/E Forward = 9.2336
P/S = 0.7758
P/B = 2.075
Revenue TTM = 2.12b CAD
EBIT TTM = 310.8m CAD
EBITDA TTM = 539.8m CAD
Long Term Debt = 1.10b CAD (from longTermDebt, last quarter)
Short Term Debt = 60.0m CAD (from shortTermDebt, last quarter)
Debt = 1.49b CAD (from shortLongTermDebtTotal, last quarter) + Leases 185.4m
Net Debt = 1.44b CAD (calculated: Debt 1.49b - CCE 44.5m)
Enterprise Value = 3.08b CAD (1.64b + Debt 1.49b - CCE 44.5m)
Interest Coverage Ratio = 2.85 (Ebit TTM 310.8m / Interest Expense TTM 109.2m)
EV/FCF = 14.08x (Enterprise Value 3.08b / FCF TTM 218.9m)
FCF Yield = 7.10% (FCF TTM 218.9m / Enterprise Value 3.08b)
FCF Margin = 10.34% (FCF TTM 218.9m / Revenue TTM 2.12b)
Net Margin = 7.04% (Net Income TTM 148.9m / Revenue TTM 2.12b)
Gross Margin = 20.26% ((Revenue TTM 2.12b - Cost of Revenue TTM 1.69b) / Revenue TTM)
Gross Margin QoQ = 18.13% (prev 19.11%)
Tobins Q-Ratio = 1.16 (Enterprise Value 3.08b / Total Assets 2.65b)
Interest Expense / Debt = 7.35% (Interest Expense 109.2m / Debt 1.49b)
Taxrate = 9.08% (14.9m / 163.8m)
NOPAT = 282.6m (EBIT 310.8m * (1 - 9.08%))
Current Ratio = 1.07 (Total Current Assets 483.9m / Total Current Liabilities 450.8m)
Debt / Equity = 1.84 (Debt 1.49b / totalStockholderEquity, last quarter 805.7m)
Debt / EBITDA = 2.67 (Net Debt 1.44b / EBITDA 539.8m)
Debt / FCF = 6.58 (Net Debt 1.44b / FCF TTM 218.9m)
Total Stockholder Equity = 772.9m (last 4 quarters mean from totalStockholderEquity)
RoA = 6.11% (Net Income 148.9m / Total Assets 2.65b)
RoE = 19.27% (Net Income TTM 148.9m / Total Stockholder Equity 772.9m)
RoCE = 16.57% (EBIT 310.8m / Capital Employed (Equity 772.9m + L.T.Debt 1.10b))
RoIC = 12.77% (NOPAT 282.6m / Invested Capital 2.21b)
WACC = 6.80% (E(1.64b)/V(3.13b) * Re(6.90%) + D(1.49b)/V(3.13b) * Rd(7.35%) * (1-Tc(0.09)))
Discount Rate = 6.90% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -45.82 | Cagr: -5.55%
[DCF] Terminal Value 77.97% ; FCFF base≈183.6m ; Y1≈210.5m ; Y5≈309.8m
[DCF] Fair Price = 28.72 (EV 4.66b - Net Debt 1.44b = Equity 3.22b / Shares 112.2m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: -50.78 | EPS CAGR: -8.54% | SUE: 0.0 | # QB: 0
Revenue Correlation: 77.01 | Revenue CAGR: 5.17% | SUE: 1.98 | # QB: 1
EPS current Quarter (2026-09-30): EPS=0.48 | Chg30d=-1.89% | Revisions=-29% | Analysts=5
EPS current Year (2026-12-31): EPS=1.35 | Chg30d=+1.16% | Revisions=-29% | GrowthEPS=+10.5% | GrowthRev=+14.0%
EPS next Year (2027-12-31): EPS=1.57 | Chg30d=+0.80% | Revisions=+0% | GrowthEPS=+16.6% | GrowthRev=+2.5%
[Analyst] Revisions Ratio: -27% (up=4, down=8)